1. Autophagy Apoptosis
  2. Autophagy Apoptosis
  3. Dioscin

Dioscin  (Synonyms: Collettiside III; CCRIS 4123)

Cat. No.: HY-N0124 Purity: 99.95%
SDS COA Handling Instructions

Dioscin (CCRIS 4123; Collettiside III) is a natural plant-derived steroidal saponin that has good anti-cancer activity against a variety of cancer cells. Dioscin causes DNA damage and induces apoptosis in HeLa and SiHa cells. Dioscin regulates ROS-mediated DNA damage and mitochondrial signaling pathways, exerting anticancer activity.

For research use only. We do not sell to patients.

Dioscin Chemical Structure

Dioscin Chemical Structure

CAS No. : 19057-60-4

Size Price Stock Quantity
Free Sample (0.1 - 0.5 mg)   Apply Now  
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
USD 84 In-stock
Solution
10 mM * 1 mL in DMSO USD 84 In-stock
Solid
5 mg USD 55 In-stock
10 mg USD 88 In-stock
50 mg USD 319 In-stock
100 mg   Get quote  
200 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 12 publication(s) in Google Scholar

Other Forms of Dioscin:

Top Publications Citing Use of Products

    Dioscin purchased from MedChemExpress. Usage Cited in: Int Immunopharmacol. 2023 Feb 19;117:109839.  [Abstract]

    Dioscin-Medium group (5 mg/kg; p.o.; every-two days for 12 weeks) profoundly inhibits the phosphorylation of NF-ĸB in mice (Fig H and I). Dioscin-Low (Dio-L, 2.5 mg/kg), Dioscin-Medium (Dio-M, 5 mg/kg) and Dioscin-High (Dio-H, 10 mg/Kg).

    Dioscin purchased from MedChemExpress. Usage Cited in: Mol Med Rep. 2017 Oct;16(4):4922-4926.  [Abstract]

    Dioscin concentrations of 0.5, 1, 5, 10 and 25 µg/mL promotes the expression of ALP and inhibits the expression of LC3B in MC3T3-E1 cells, in a concentration-dependent manner.
    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Dioscin (CCRIS 4123; Collettiside III) is a natural plant-derived steroidal saponin that has good anti-cancer activity against a variety of cancer cells. Dioscin causes DNA damage and induces apoptosis in HeLa and SiHa cells. Dioscin regulates ROS-mediated DNA damage and mitochondrial signaling pathways, exerting anticancer activity[1][2][3][4][5][6].

    Cellular Effect
    Cell Line Type Value Description References
    A2780 IC50
    0.581 μM
    Compound: Dioscin
    Cytotoxicity against human A2780 cells by MTT assay
    Cytotoxicity against human A2780 cells by MTT assay
    [PMID: 21482468]
    A2780 IC50
    0.87 μM
    Compound: Dioscin
    Cytotoxicity against human A2780 cells by MTT assay
    Cytotoxicity against human A2780 cells by MTT assay
    [PMID: 22429911]
    A2780 IC50
    4.46 μM
    Compound: Dioscin
    Cytotoxicity against human A2780 cells after 72 hrs by MTT assay
    Cytotoxicity against human A2780 cells after 72 hrs by MTT assay
    [PMID: 19362474]
    A549 IC50
    0.454 μM
    Compound: Dioscin
    Cytotoxicity against human A549 cells by MTT assay
    Cytotoxicity against human A549 cells by MTT assay
    [PMID: 21482468]
    A549 IC50
    0.7 μM
    Compound: Dioscin
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    Cytotoxicity against human A549 cells after 72 hrs by MTT assay
    [PMID: 19362474]
    A549 IC50
    0.81 μM
    Compound: Dioscin
    Cytotoxicity against human A549 cells by MTT assay
    Cytotoxicity against human A549 cells by MTT assay
    [PMID: 22429911]
    A549 IC50
    4.2 μM
    Compound: dioscin
    Cytotoxicity against human A549 cells by MTT assay
    Cytotoxicity against human A549 cells by MTT assay
    [PMID: 16905317]
    BC1 cell line IC50
    3.8 μM
    Compound: 2
    Cytotoxicity against human BC1 cells after 72 hrs by SRB assay
    Cytotoxicity against human BC1 cells after 72 hrs by SRB assay
    [PMID: 12088425]
    Bel-7402 IC50
    0.23 μM
    Compound: Dioscin
    Cytotoxicity against human Bel7402 cells after 72 hrs by MTT assay
    Cytotoxicity against human Bel7402 cells after 72 hrs by MTT assay
    [PMID: 19362474]
    Bel-7402 IC50
    0.81 μM
    Compound: Dioscin
    Cytotoxicity against human Bel7402 cells by MTT assay
    Cytotoxicity against human Bel7402 cells by MTT assay
    [PMID: 22429911]
    Bel-7402 IC50
    0.93 μM
    Compound: Dioscin
    Cytotoxicity against human Bel7402 cells by MTT assay
    Cytotoxicity against human Bel7402 cells by MTT assay
    [PMID: 21482468]
    BGC-823 IC50
    0.268 μM
    Compound: Dioscin
    Cytotoxicity against human BGC823 cells by MTT assay
    Cytotoxicity against human BGC823 cells by MTT assay
    [PMID: 21482468]
    BGC-823 IC50
    1.08 μM
    Compound: Dioscin
    Cytotoxicity against human BGC823 cells by MTT assay
    Cytotoxicity against human BGC823 cells by MTT assay
    [PMID: 22429911]
    BGC-823 IC50
    2 μM
    Compound: dioscin
    Cytotoxicity against human BGC823 cells by MTT assay
    Cytotoxicity against human BGC823 cells by MTT assay
    [PMID: 16905317]
    BXPC-3 IC50
    0.7 μM
    Compound: Dioscin
    Cytotoxicity against human BxPC3 cells after 72 hrs by MTT assay
    Cytotoxicity against human BxPC3 cells after 72 hrs by MTT assay
    [PMID: 19362474]
    BXPC-3 GI50
    1.3 μg/mL
    Compound: 4, dioscin
    Growth inhibition of humanBxPC3 cells after 48 hrs
    Growth inhibition of humanBxPC3 cells after 48 hrs
    [PMID: 15921418]
    Capan-2 IC50
    0.05 μM
    Compound: Dioscin
    Cytotoxicity against human Capan2 cells after 72 hrs by MTT assay
    Cytotoxicity against human Capan2 cells after 72 hrs by MTT assay
    [PMID: 19362474]
    Col2 IC50
    2.8 μM
    Compound: 2
    Cytotoxicity against human Col2 cells after 72 hrs by SRB assay
    Cytotoxicity against human Col2 cells after 72 hrs by SRB assay
    [PMID: 12088425]
    DU-145 GI50
    > 10 μg/mL
    Compound: 4, dioscin
    Growth inhibition of human DU145 cells after 48 hrs
    Growth inhibition of human DU145 cells after 48 hrs
    [PMID: 15921418]
    HCT-8 IC50
    0.34 μM
    Compound: Dioscin
    Cytotoxicity against human HCT8 cells by MTT assay
    Cytotoxicity against human HCT8 cells by MTT assay
    [PMID: 22429911]
    HCT-8 IC50
    0.351 μM
    Compound: Dioscin
    Cytotoxicity against human HCT8 cells by MTT assay
    Cytotoxicity against human HCT8 cells by MTT assay
    [PMID: 21482468]
    HCT-8 IC50
    0.56 μM
    Compound: Dioscin
    Cytotoxicity against human HCT8 cells after 72 hrs by MTT assay
    Cytotoxicity against human HCT8 cells after 72 hrs by MTT assay
    [PMID: 19362474]
    HeLa IC50
    0.5 μM
    Compound: Dioscin
    Cytotoxicity against human HeLa cells by MTT assay
    Cytotoxicity against human HeLa cells by MTT assay
    [PMID: 22429911]
    HGC-27 IC50
    5.9 μM
    Compound: dioscin
    Cytotoxicity against human HGC27 cells by MTT assay
    Cytotoxicity against human HGC27 cells by MTT assay
    [PMID: 16905317]
    HL-60 IC50
    2 μM
    Compound: 6
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
    [PMID: 12828464]
    HL-60 IC50
    3.8 μM
    Compound: 1
    Cytotoxicity against human HL60 cells assessed as cell viability after 72 hrs by MTT assay
    Cytotoxicity against human HL60 cells assessed as cell viability after 72 hrs by MTT assay
    [PMID: 22405922]
    K562 IC50
    4.7 μM
    Compound: 1
    Cytotoxicity against human K562 cells assessed as cell viability after 48 hrs by MTT assay
    Cytotoxicity against human K562 cells assessed as cell viability after 48 hrs by MTT assay
    [PMID: 23621869]
    K562/Adr IC50
    3.3 μM
    Compound: 1
    Cytotoxicity against human K562/ADR cells assessed as cell viability after 48 hrs by MTT assay
    Cytotoxicity against human K562/ADR cells assessed as cell viability after 48 hrs by MTT assay
    [PMID: 23621869]
    KB IC50
    0.53 μM
    Compound: Dioscin
    Cytotoxicity against human KB cells by MTT assay
    Cytotoxicity against human KB cells by MTT assay
    [PMID: 22429911]
    KB IC50
    20.7 μM
    Compound: 2
    Cytotoxicity against human KB cells after 72 hrs by SRB assay
    Cytotoxicity against human KB cells after 72 hrs by SRB assay
    [PMID: 12088425]
    KB ED50
    21 μM
    Compound: 8
    Growth inhibition of human KB cells xenografted in ip dosed NCr nu/nu mouse administered once daily from day 3 to 6 after implantation measured on day 7 by MTT-based hollow-fiber test
    Growth inhibition of human KB cells xenografted in ip dosed NCr nu/nu mouse administered once daily from day 3 to 6 after implantation measured on day 7 by MTT-based hollow-fiber test
    [PMID: 19161316]
    KB-V1 IC50
    > 23 μM
    Compound: 2
    Cytotoxicity against human KBV1 cells after 72 hrs by SRB assay
    Cytotoxicity against human KBV1 cells after 72 hrs by SRB assay
    [PMID: 12088425]
    KETR3 IC50
    0.447 μM
    Compound: Dioscin
    Cytotoxicity against human Ketr3 cells by MTT assay
    Cytotoxicity against human Ketr3 cells by MTT assay
    [PMID: 21482468]
    KM-20L2 GI50
    1.3 μg/mL
    Compound: 4, dioscin
    Growth inhibition of human KM20L2 cells after 48 hrs
    Growth inhibition of human KM20L2 cells after 48 hrs
    [PMID: 15921418]
    LNCaP IC50
    1.7 μM
    Compound: 2
    Cytotoxicity against human LNCAP cells after 72 hrs by SRB assay
    Cytotoxicity against human LNCAP cells after 72 hrs by SRB assay
    [PMID: 12088425]
    LNCaP ED50
    1.7 μM
    Compound: 8
    Growth inhibition of human LNCAP cells xenografted in ip dosed NCr nu/nu mouse administered once daily from day 3 to 6 after implantation measured on day 7 by MTT-based hollow-fiber test
    Growth inhibition of human LNCAP cells xenografted in ip dosed NCr nu/nu mouse administered once daily from day 3 to 6 after implantation measured on day 7 by MTT-based hollow-fiber test
    [PMID: 19161316]
    Lu1 IC50
    1.2 μM
    Compound: 2
    Cytotoxicity against human Lu1 cells after 72 hrs by SRB assay
    Cytotoxicity against human Lu1 cells after 72 hrs by SRB assay
    [PMID: 12088425]
    Lu1 ED50
    1.2 μM
    Compound: 8
    Growth inhibition of human Lu1 cells xenografted in ip dosed NCr nu/nu mouse administered once daily from day 3 to 6 after implantation measured on day 7 by MTT-based hollow-fiber test
    Growth inhibition of human Lu1 cells xenografted in ip dosed NCr nu/nu mouse administered once daily from day 3 to 6 after implantation measured on day 7 by MTT-based hollow-fiber test
    [PMID: 19161316]
    MCF7 GI50
    0.68 μg/mL
    Compound: 4, dioscin
    Growth inhibition of human MCF7 cells after 48 hrs
    Growth inhibition of human MCF7 cells after 48 hrs
    [PMID: 15921418]
    MCF7 IC50
    0.879 μM
    Compound: Dioscin
    Cytotoxicity against human MCF7 cells by MTT assay
    Cytotoxicity against human MCF7 cells by MTT assay
    [PMID: 21482468]
    MCF7 IC50
    1.03 μM
    Compound: Dioscin
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
    [PMID: 19362474]
    MCF7 IC50
    22.4 μM
    Compound: 2
    Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay
    Cytotoxicity against human MCF7 cells after 72 hrs by SRB assay
    [PMID: 12088425]
    NCI-H460 GI50
    1.8 μg/mL
    Compound: 4, dioscin
    Growth inhibition of human NCI-H460 cells after 48 hrs
    Growth inhibition of human NCI-H460 cells after 48 hrs
    [PMID: 15921418]
    NCI-H460 IC50
    4.56 μM
    Compound: 12
    Cytotoxicity against human NCI-H460 cells incubated for 24 hrs by MTT assay
    Cytotoxicity against human NCI-H460 cells incubated for 24 hrs by MTT assay
    [PMID: 28606759]
    P388 ED50
    > 10 μg/mL
    Compound: 4, dioscin
    Growth inhibition of mouse P388 cells after 48 hrs
    Growth inhibition of mouse P388 cells after 48 hrs
    [PMID: 15921418]
    P388 IC50
    21.9 μM
    Compound: 2
    Cytotoxicity against mouse P388 cells after 72 hrs by SRB assay
    Cytotoxicity against mouse P388 cells after 72 hrs by SRB assay
    [PMID: 12088425]
    PANC-1 IC50
    0.81 μM
    Compound: Dioscin
    Cytotoxicity against human PANC1 cells after 72 hrs by MTT assay
    Cytotoxicity against human PANC1 cells after 72 hrs by MTT assay
    [PMID: 19362474]
    SF-268 GI50
    1.2 μg/mL
    Compound: 4, dioscin
    Growth inhibition of human SF268 cells after 48 hrs
    Growth inhibition of human SF268 cells after 48 hrs
    [PMID: 15921418]
    SK-MEL-2 IC50
    1.8 μM
    Compound: 2
    Cytotoxicity against human SK-MEL-2 cells after 72 hrs by SRB assay
    Cytotoxicity against human SK-MEL-2 cells after 72 hrs by SRB assay
    [PMID: 12088425]
    SW1990 IC50
    0.5 μM
    Compound: Dioscin
    Cytotoxicity against human SW1990 cells after 72 hrs by MTT assay
    Cytotoxicity against human SW1990 cells after 72 hrs by MTT assay
    [PMID: 19362474]
    SW626 IC50
    3.1 μM
    Compound: 2
    Cytotoxicity against human SW626 cells after 72 hrs by SRB assay
    Cytotoxicity against human SW626 cells after 72 hrs by SRB assay
    [PMID: 12088425]
    In Vitro

    Dioscin (1.25-5 μg/mL; 6-24 h) increases intracellular calcium levels and induces apoptosis in HeLa and SiHa cells[4].
    Dioscin (1.25-5 μg/mL; 6-24 h) Dioscin up-regulates the protein levels of Bak, Bax, Bid, p53, caspase-3, caspase-9, and down-regulates the proteins of Bcl-2 and Bcl-xl level[4].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    In Vivo

    Dioscin (75-300 mg/kg, 10 mL/kg; oral gavage; 90 days) has no subchronic toxicity in female rats and mild subchronic toxicity in male rats. Dioscin caused mild gastrointestinal dilatation in male rats and demonstrated hemolytic anemia on hematological evaluation[5].
    Dioscin can reduce liver ischemia-reperfusion injury in rats by inhibiting oxidative-nitrative stress, inflammation and apoptosis[6].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Molecular Weight

    869.04

    Formula

    C45H72O16

    CAS No.
    Appearance

    Solid

    Color

    White to off-white

    SMILES

    O[C@@H]1[C@@H](O)[C@H](C)O[C@@]([H])(O[C@H]2[C@H](O)[C@@H](O[C@]3([H])O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@@](O[C@@H]4CC5=CC[C@]([C@]([H])(C[C@@]6([H])[C@]7([H])[C@H](C)[C@]8(OC[C@H](C)CC8)O6)[C@]7(C)CC9)([H])[C@@]9([H])[C@@]5(C)CC4)([H])O[C@@H]2CO)[C@@H]1O

    Structure Classification
    Initial Source
    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage
    Powder -20°C 3 years
    4°C 2 years
    In solvent -80°C 2 years
    -20°C 1 year
    Solvent & Solubility
    In Vitro: 

    DMSO : ≥ 100 mg/mL (115.07 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    *"≥" means soluble, but saturation unknown.

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 1.1507 mL 5.7535 mL 11.5070 mL
    5 mM 0.2301 mL 1.1507 mL 2.3014 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 2.25 mg/mL (2.59 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.25 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (22.5 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: ≥ 2.25 mg/mL (2.59 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.25 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (22.5 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.

    For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  0.5% CMC-Na/saline water

      Solubility: 5 mg/mL (5.75 mM); Suspended solution; Need ultrasonic

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    Purity & Documentation

    Purity: 99.95%

    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 1.1507 mL 5.7535 mL 11.5070 mL 28.7674 mL
    5 mM 0.2301 mL 1.1507 mL 2.3014 mL 5.7535 mL
    10 mM 0.1151 mL 0.5753 mL 1.1507 mL 2.8767 mL
    15 mM 0.0767 mL 0.3836 mL 0.7671 mL 1.9178 mL
    20 mM 0.0575 mL 0.2877 mL 0.5753 mL 1.4384 mL
    25 mM 0.0460 mL 0.2301 mL 0.4603 mL 1.1507 mL
    30 mM 0.0384 mL 0.1918 mL 0.3836 mL 0.9589 mL
    40 mM 0.0288 mL 0.1438 mL 0.2877 mL 0.7192 mL
    50 mM 0.0230 mL 0.1151 mL 0.2301 mL 0.5753 mL
    60 mM 0.0192 mL 0.0959 mL 0.1918 mL 0.4795 mL
    80 mM 0.0144 mL 0.0719 mL 0.1438 mL 0.3596 mL
    100 mM 0.0115 mL 0.0575 mL 0.1151 mL 0.2877 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Salutation

    Applicant Name *

     

    Email Address *

    Phone Number *

     

    Organization Name *

    Department *

     

    Requested quantity *

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Dioscin
    Cat. No.:
    HY-N0124
    Quantity:
    MCE Japan Authorized Agent: